Telephone: +31-30-212-1905; Fax: +31-30-251-6464;
Cancer Stem Cells
Brief Report: Intravital Imaging of Cancer Stem Cell Plasticity in Mammary Tumors†‡§
Article first published online: 25 FEB 2013
DOI: 10.1002/stem.1296
Copyright © 2012 AlphaMed Press
Additional Information
How to Cite
Zomer, A., Ellenbroek, S. I. J., Ritsma, L., Beerling, E., Vrisekoop, N. and Van Rheenen, J. (2013), Brief Report: Intravital Imaging of Cancer Stem Cell Plasticity in Mammary Tumors. STEM CELLS, 31: 602–606. doi: 10.1002/stem.1296
- †
Author contributions: A.Z.: collection and assembly of the data, data analysis and interpretation, manuscript writing, and final approval of the manuscript; S.I.J.E. and N.V.: data analysis and interpretation, manuscript writing, and final approval of the manuscript; L.R.: developed the mammary imaging window, collection and assembly of the data, and final approval of the manuscript; E.B.: collection and assembly of the data and final approval of the manuscript; J.v.R.: conception and design, financial support, manuscript writing, and final approval of the manuscript.
- ‡
Disclosure of potential conflicts of interest is found at the end of this article.
- §
First published online in STEM CELLSEXPRESS December 7, 2012.
- ¶
Telephone: +31-30-212-1905; Fax: +31-30-251-6464;
Publication History
- Issue published online: 25 FEB 2013
- Article first published online: 25 FEB 2013
- Accepted manuscript online: 7 DEC 2012 05:35AM EST
- Manuscript Accepted: 15 NOV 2012
- Manuscript Received: 29 AUG 2012
Funded by
- VIDI. Grant Number: 91710330
- Dutch Organization of Scientific Research (NWO)
- Dutch Cancer Society
- KWF
- HUBR. Grant Number: 2009-4621
- Association for International Cancer Research (AICR, 13-0297). Grant Numbers: 175.010.2007.00, 834.11.002
- Dutch Organization of Scientific Research (NWO)
- Abstract
- Article
- References
- Supporting Information
- Cited By
Additional Supporting Information may be found in the online version of this article.
| Filename | Format | Size | Description |
|---|---|---|---|
| sc-12-0811_sm_SupplFigure1.pdf | 195K | Supporting Information Figure S1. PyMT expression induced the formation of adenomas that progressed to carcinomas. Shown are two histological images of sections of a PyMT adenoma (left) and a PyMT carcinoma (right) stained for hematoxylin (purple) and smooth muscle actin (brown). Note that in the adenoma the smooth muscle actin-positive basement membrane is still present, but is lacking in the carcinoma. Moreover, tumor cells in the carcinoma invade the surrounding stroma (marked by the asterisk). Scale bars, 50 μm. | |
| sc-12-0811_sm_SupplFigure2.pdf | 120K | Supporting Information Figure S2. PyMT tumor growth was not detectable affected by the induction of the confetti randomizer using tamoxifen. (A): Shown are histological images of sections of a PyMT tumor treated or not treated with tamoxifen stained for hematoxylin and eosin. Scale bars, 50 μm. (B): Other PyMT sections of the same tumors as in A were stained with an anti-Ki67 antibody, and the number of proliferative cells per imaging field (i.f.) was analyzed (N=25). The average number and standard error of the mean of proliferative Ki67+ cells were plotted. (C): Other sections were stained for apoptotic cells with an anti cleaved caspase-3 antibody. The average number and standard error of the mean of apoptotic cells per imaging field (N=25) were plotted. Shown are the average number and standard error of the mean. (D): Growth of PyMT tumors in control (gray line) and tamoxifen-treated animals (red line) plotted over time. Shown are the average values and standard error of the mean for 4 mice. |
Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

1549-4918/asset/olbannerleft.jpg?v=1&s=699114e871887e6b838f6a1c657fe256cfe127a6)
1549-4918/asset/olbannerright.gif?v=1&s=603f8f2ab5cd9d4f783c231915608956af51aeea)
